Logo

Gene Logic Reports Increased Revenue, Losses

Oct 24, 2003

NEW YORK, Oct. 24 (GenomeWeb News) - Gene Logic of Gaithersburg, Md. today reported a 25 percent increase in year-over-year revenues for the third quarter, posting $17.7 million in revenues this quarter compared with $14.2 in the third quarter of 2002. The company attributed the increase to its recent acquisition of TherImmune Research, which was completed April 1. This increase is down from a 38 percent increase year-over-year in the second quarter of 2003.

 

Gene Logic's net losses for the quarter were $10.1 million, compared with $7 million in the year-ago period. The company spent $540,000 on R&D, compared with $641,000 in 2002.

 

As of Sept. 30, the company had $71 million in cash and cash equivalents.

 

Breaking News
The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.